Previda®
Preimplantation Genetic Testing for Aneuploidies
(PGT-A)
Menu
Your physician will receive your results through our online medical portal Revela®. Euploid embryos are generally associated with high implantation rates and are recommended for transfer. Aneuploid embryos are not recommended for transfer because they can result in implantation failure, miscarriage, or developmental disorders in newborns.
The role of mosaicism in IVF is an ongoing research initiative, but these embryos are typically not recommended for transfer. Genetic counseling is highly recommended when considering transfer of mosaic embryos.
At Progenesis, our patients are our highest priority.
We are happy to address any of your questions or concerns.
Progenesis Inc.
Address: 4150 Regents Park Row,
Suite 245,
La Jolla, CA 92037
Phone: (858) 257-2122
Fax: (888) 810-6079
Progenesis is a San Diego based company that develops and offers genetic testing services for patients throughout their family planning journey. Progenesis was the first company in the U.S. to offer Next Generation Sequencing (NGS) for preimplantation genetic testing. Through optimization of the NGS platform, Progenesis confidently maintains the most accurate testing in the IVF field with the lowest rate of mosaicism.
